Literature DB >> 15971503

A community-based follow-up study on diabetic retinopathy among type 2 diabetics in Kinmen.

Tao-Hsin Tung1, Shih-Jen Chen, Jorn-Hon Liu, Fenq-Lih Lee, An-Fei Li, Mong-Ping Shyong, Pesus Chou.   

Abstract

The purpose of this follow-up study was conducted to assess the incidence and risk factors of diabetic retinopathy (DR) among type 2 diabetics in Kinmen, Taiwan. A penal of eye screening regimes were performed yearly for 971 type 2 diabetics by two senior ophthalmologists using indirect ophthalmoscopy and 45-degree color fundus photography to examine fundus after dilating pupils from 1999 to 2002. 74.7% (725/971) of diabetics had been screened at least two times during this period. Among the 548 type 2 diabetics who had no DR at first screening, 93 subjects developed any type of DR. The 3-year 18.2% cumulative incidence was (95% CI: 14.8-21.5%) and incidence density was 6.62% per year (95% CI: 5.36-8.06% per year). Using Cox regression model, HbAlc revealed the significantly dose response relationship to the development of DR (chi2-test for trend = 9.41, p < 0.05) after controlling for confounding factors. Other independent predictors related to the development of DR included duration of diabetes (RR: 1.09, 95% CI: 1.05-1.13), higher systolic blood pressure (>140 vs. < 140 mm Hg, RR: 1.96, 95% CI: 1.23-3.12), and higher triglyceride (> 200 vs. < 200 mg/dl, RR: 1.60, 95% CI: 1.01-2.54). In conclusion, in addition to poor glycemic control of which is the most significant risk factor for the development of DR, longer duration of diabetes, higher systolic blood pressure, and elevated serum triglyceride levels were also associated with the development of DR among type 2 diabetics in Kinmen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15971503     DOI: 10.1007/s10654-004-6651-z

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  30 in total

Review 1.  Diabetes mellitus. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1985

2.  Cardiovascular mortality and morbidity in type-2 diabetes mellitus.

Authors:  G Schernthaner
Journal:  Diabetes Res Clin Pract       Date:  1996-07       Impact factor: 5.602

3.  Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. San Luis Valley Diabetes Study, Colorado.

Authors:  S M Tudor; R F Hamman; A Baron; D W Johnson; S M Shetterly
Journal:  Diabetes Care       Date:  1998-01       Impact factor: 19.112

4.  A four-year follow-up study on the incidence of diabetic retinopathy in older onset diabetes mellitus.

Authors:  E Agardh; C D Agardh; S Koul; O Torffvit
Journal:  Diabet Med       Date:  1994-04       Impact factor: 4.359

5.  Diabetic retinopathy I. The course of retinopathy in insulin-treated diabetics. A one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark.

Authors:  N V Nielsen
Journal:  Acta Ophthalmol (Copenh)       Date:  1984-04

6.  Screening for diabetic retinopathy. The wide-angle retinal camera.

Authors:  J A Pugh; J M Jacobson; W A Van Heuven; J A Watters; M R Tuley; D R Lairson; R J Lorimor; A S Kapadia; R Velez
Journal:  Diabetes Care       Date:  1993-06       Impact factor: 19.112

7.  Diabetic retinopathy II. The course of retinopathy in diabetics treated with oral hypoglycaemic agents and diet regime alone. A one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark.

Authors:  N V Nielsen
Journal:  Acta Ophthalmol (Copenh)       Date:  1984-04

8.  Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study.

Authors:  Wen-Ming Hsu; Ching-Yu Cheng; Jorn-Hon Liu; Su-Ying Tsai; Pesus Chou
Journal:  Ophthalmology       Date:  2004-01       Impact factor: 12.079

9.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors:  Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

10.  The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

Authors: 
Journal:  Diabetes       Date:  1995-08       Impact factor: 9.461

View more
  7 in total

1.  Association of Olfactory Impairment With All-Cause Mortality: A Systematic Review and Meta-analysis.

Authors:  Natalie Yan-Lin Pang; Harris Jun Jie Muhammad Danial Song; Benjamin Kye Jyn Tan; Jun Xiang Tan; Ashley Si Ru Chen; Anna See; Shuhui Xu; Tze Choong Charn; Neville Wei Yang Teo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2022-05-01       Impact factor: 8.961

2.  Incidence Density and Risk Factors of Diabetic Retinopathy Within Type 2 Diabetes: A Five-Year Cohort Study in China (Report 1).

Authors:  Lei Liu; Jingyang Wu; Song Yue; Jin Geng; Jie Lian; Weiping Teng; Desheng Huang; Lei Chen
Journal:  Int J Environ Res Public Health       Date:  2015-07-10       Impact factor: 3.390

Review 3.  Relationship between dyslipidemia and diabetic retinopathy: A systematic review and meta-analysis.

Authors:  Yue Zhou; Changyun Wang; Ke Shi; Xiaolong Yin
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

4.  Incidence of diabetes retinopathy and determinants of time to diabetes retinopathy among diabetes patients at Tikur Anbessa Hospital, Ethiopia: a retrospective follow up study.

Authors:  Tabot Keskis Azeze; Malede Mequanent Sisay; Ejigu Gebeye Zeleke
Journal:  BMC Res Notes       Date:  2018-08-02

5.  Factors associated with retinal screening among patients with diabetes in Taiwan.

Authors:  Pai-Huei Peng; Sarah B Laditka; Huey-Shyan Lin; Hui-Chen Lin; Janice C Probst
Journal:  Taiwan J Ophthalmol       Date:  2019-09-12

6.  Economic evaluation of screening for diabetic retinopathy among Chinese type 2 diabetics: a community-based study in Kinmen, Taiwan.

Authors:  Tao-Hsin Tung; Hui-Chuan Shih; Shih-Jen Chen; Pesus Chou; Chi-Ming Liu; Jorn-Hon Liu
Journal:  J Epidemiol       Date:  2008-09-08       Impact factor: 3.211

7.  Metformin Treatment Is Associated with a Decreased Risk of Nonproliferative Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study.

Authors:  Yu-Pei Fan; Chien-Tung Wu; Jiun-Lu Lin; Chao A Hsiung; Hsiao Yu Liu; Jung-Nien Lai; Chen-Chang Yang
Journal:  J Diabetes Res       Date:  2020-04-19       Impact factor: 4.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.